TrueMark Investments’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
TrueMark Investments's BCAT Position: Q1 2026 in Review
TrueMark Investments sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q1 2026, closing a stake of 28,859 shares — an estimated $409K sold.
TrueMark Investments first reported a position in BCAT in Q4 2025 and held it in 1 quarter. The position peaked at $409K in Q4 2025. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.
- TrueMark Investments reported no remaining BlackRock Capital Allocation Term Trust position as of Q1 2026 after selling out during the quarter.
- TrueMark Investments sold 28,859 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $409K.
- TrueMark Investments first reported a position in BlackRock Capital Allocation Term Trust in Q4 2025 and held it in 1 quarter.
- TrueMark Investments's BlackRock Capital Allocation Term Trust position peaked at $409K in Q4 2025.
- 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.
Based on TrueMark Investments's 13F filing for Q1 2026, filed 20 Apr 2026.